Reported cases of COVID-19-associated immune thrombocytopenic purpura
Case | Presenting symptoms | COVID symptoms present before or on admission? | Hospital day of decrease in platelet count | Initial platelet count (× 109/L) | First ITP intervention | Platelet count after first ITP intervention (× 109/L) | Second ITP intervention (if applicable) | Platelet count after second ITP intervention (×109/L) |
---|---|---|---|---|---|---|---|---|
Hindilerdin et al22 | Easy bruising, fatigue, fever, dry cough | Yes | Day 0 | 10 | IVIG 1 g/kg × 2 days | 25 | Prednisolone 1 mg/kg/day × 10 days | 100 |
Tsao et al23 | Rash, purple lesions in mouth, bruising | Yes | Day 0 | 5 | IVIG 1 g/kg once | 320 | N/A | N/A |
Artru et al24 | Dyspnea, fever, cough, asthenia | Yes | Day 4 | 1 | IVIG 0.4 g/kg × 5 days Dexamethasone 40 mg/day × 4 days | 30 | Dexamethasone 40 mg/day × 4 days | 75 |
Bennett et al25 | Fever, dyspnea, diarrhea, cough | Yes | Day 0 | < 3 | IVIG 1g/kg × 2 days | 105 | N/A | N/A |
Levesque et al26 | Dyspnea, dry cough, fever | Yes | Day 20 | 23 | IVIG 1 g/kg × 2 days Dexamethasone 40 mg × 4 days | < 10 | Romiplostim daily × 10 days Vincristine × 1 day Methylprednisolone 500 mg IV × 4 days | 178 |
Murt et al27 | Petechiae, easy bruising | Yes | Day 0 | 9 | IVIG 2 g/kg × 2 days | 54 | N/A | N/A |
Bomhof et al28 | ||||||||
Patient 1 | Oral mucosal petechiae, spontaneous skin hematomas | Yes | Day 0 | < 3 | Platelet transfusion IVIG 1 g/kg × 2 days | 47 | Dexamethasone | 51 |
Patient 2 | Petechiae, bleeding from hemorrhoids, epistaxis | Yes | Day 0 | 2 | Platelet transfusion Dexamethasone 40 mg daily × 4 days | 2 | IVIG | 32 |
Patient 3 | Fever, coughing, dyspnea | Yes | Day 12 | 3 | N/A | N/A | N/A | N/A |
Granat et al (current case) | None | N/A | 0 | 3 | Platelet transfusion Dexamethasone 40 mg × 1 day | 67 | Prednisone 1 mg/kg × 4 days | 268 |
ITP = immune thrombocytopenic purpura; IVIG = intravenous immunoglobulin; N/A = not available